Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

• Federica Cappuccini,
• Emily Pollock,
• Irina Redchenko,
• Benoit J Van den Eynde,
• James McAuliffe,
• Hok Fung Chan,
• Laurine Noblecourt,
• Ramiro Andrei Ramirez-Valdez,
• Vinnycius Pereira-Almeida,
• Yaxuan Zhou,
• Adrian VS Hill,
• Carol Sze Ki Leung

Affiliations

Federica Cappuccini

The Jenner Institute, Nuffield Department of Medicine, University of oxford, Oxford, UK

Emily Pollock

The Jenner Institute, Nuffield Department of Medicine, University of oxford, Oxford, UK

Irina Redchenko

The Jenner Institute, Nuffield Department of Medicine, University of oxford, Oxford, UK

Benoit J Van den Eynde

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

James McAuliffe

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Hok Fung Chan

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Laurine Noblecourt

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Ramiro Andrei Ramirez-Valdez

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Vinnycius Pereira-Almeida

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Yaxuan Zhou

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Adrian VS Hill

The Jenner Institute, Nuffield Department of Medicine, University of oxford, Oxford, UK

Carol Sze Ki Leung

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK